Strepsils Intensive spray d / mestn. apply. dosage 8.75mg / dose vial 15ml

Special Price $12.61 Regular Price $21.00
In stock
SKU
OTC10202410
252.2 Reward Points will be used to purchase this product

Category

Sore throat

Scope of the medicinal product

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Thailand

Package quantity, pcs

one

Description

Structure

1 dose (3 sprays) contains flurbiprofen 8.75 mg

Excipients: Betadex 22.83 mg

sodium hydrogen phosphate dodecahydrate 17.19 mg

citric acid monohydrate 0.63 mg, methyl parahydroxybenzoate 1.18 mg

propyl parahydroxybenzoate 0.24mg

sodium hydroxide 1.30 mg

Mint Flavor (PHL 175628) 1.08 mg

cherry flavor (PHL 175629) 1.35 mg

N-2,3-trimethyl-2-isopropylbutanamide 0.54mg

sodium saccharin 0.27 mg

hydroxypropylbetadex 12.09 mg

water 492.55 mg.

pharmachologic effect

Non-steroidal anti-inflammatory drug

Indications

As a symptomatic agent for the relief of sore throat in infectious and inflammatory diseases of the upper respiratory tract

Application during pregnancy and lactation

The use of the drug in the third trimester of pregnancy is contraindicated.

Avoid the use of flurbiprofen in the I and II trimesters of pregnancy, if necessary, the use of the drug, you should consult your doctor.

There is evidence that small amounts of flurbiprofen can pass into breast milk without any negative consequences for the health of an infant, however, due to the possible side effects of NSAIDs, the use of the drug during breastfeeding is not recommended.

Contraindications

Hypersensitivity to flurbiprofen or to any of the other components of the drug.

a history of hypersensitivity reactions (bronchial asthma, bronchospasm, rhinitis, Quincke's edema, urticaria, recurrent polyposis of the nose or paranasal sinuses) in response to the use of acetylsalicylic acid or other NSAIDs

erosive and ulcerative diseases of the gastrointestinal tract (including peptic ulcer of the stomach and duodenum), ulcerative bleeding in phase or in history (2 or more confirmed episodes of peptic ulcer or ulcerative bleeding):

bleeding or perforation of the gastrointestinal tract ulcer, ulcerative colitis, hemorrhagic and hematopoietic disorders in the history, provoked by the use of NSAIDs

pregnancy (III trimester)

period of breastfeeding

children under 12 years old

severe liver failure or active liver disease

renal failure of severe severity (CC < 30 ml / min)

decompensated heart failure

the period after coronary artery bypass grafting

confirmed hyperkalemia

deficiency of glucose-6-phosphate dehydrogenase

hemophilia and other blood clotting disorders (including hypocoagulation), hemorrhagic diathesis.

With caution and only after consulting a doctor, you should take the drug if you have a history of a single episode of gastric ulcer or ulcerative bleeding of the gastrointestinal tract a history of gastrointestinal diseases (ulcerative colitis, Crohn's disease), gastritis, enteritis, colitis, the presence of Helicobacter pylori infection bronchial asthma or allergic diseases in the stage of exacerbation or in history (development of bronchospasm is possible) systemic lupus erythematosus or mixed connective tissue disease (Sharp's syndrome), because increased risk of aseptic meningitis (with short-term use of flurbiprofen, the risk is negligible) renal failure, incl. with dehydration (CC less than 30-60 ml / min), nephrotic syndrome liver failure liver cirrhosis with portal hypertension hyperbilirubinemia arterial hypertension and / or heart failure, edema concomitant use of other NSAIDs the simultaneous use of drugs that can increase the risk of ulcers or bleeding, in particular GCS for oral administration (including prednisolone), anticoagulants (including warfarin), antiplatelet agents (including acetylsalicylic acid, clopidogrel ), selective serotonin reuptake inhibitors (including citalopram, fluoxetine, paroxetine, sertraline) in the I and II trimesters of pregnancy, during breastfeeding patientacetylsalicylic acid, clopidogrel), selective serotonin reuptake inhibitors (including citalopram, fluoxetine, paroxetine, sertraline) in the I and II trimesters of pregnancy, during breastfeeding patientacetylsalicylic acid, clopidogrel), selective serotonin reuptake inhibitors (including citalopram, fluoxetine, paroxetine, sertraline) in the I and II trimesters of pregnancy, during breastfeeding patient

Name ENG

STREPSILS INTENSIV

Clinical and pharmacological group

Drug with antimicrobial and local anesthetic action for local use in ENT practice and dentistry

ATX code

Flurbiprofen

Dosage

8.75mg / dose x 15ml

Structure

dose (3 sprays) contains flurbiprofen 8.75 mg Excipients: Betadex 22.83 mg

sodium hydrogen phosphate dodecahydrate 17.19 mg

citric acid monohydrate 0.63 mg, methyl parahydroxybenzoate 1.18 mg

propyl parahydroxybenzoate 0.24mg

sodium hydroxide 1.30 mg

Mint Flavor (PHL 175628) 1.08 mg

cherry flavor (PHL 175629) 1.35 mg

N-2,3-trimethyl-2-isopropylbutanamide 0.54mg

sodium saccharin 0.27 mg

hydroxypropylbetadex 12.09 mg

water 492.55 mg.

INN / Active ingredient

Flurbiprofen

Storage conditions and periods

At a temperature not exceeding 30 degrees (do not store in the refrigerator, do not freeze).

Expiration date: 2 years

after opening - 6 months

Specifications

Category

Sore throat

Scope of the medicinal product

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Thailand

Package quantity, pcs

one

Minimum age from

12 years

Way of introduction

Through the respiratory tract

Vacation conditions

Without recipe

Volume, ml.

15 ml

Brand name

Reckitt benckiser

The amount of the dosage form in the primary package

15 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Non-steroidal anti-inflammatory drug

Anatomical and therapeutic characteristics

R02AX01 Flurbiprofen

Dosage form

Dosed topical spray

The target audience

Children

Dosage (volume) of the substance in the preparation

flurbiprofen 8.75 mg

Expiration date in days

730

Package weight, g

5

Mode of application

:

Read the instructions carefully before using the drug.

For topical use.

For short term use only.

Adults and children over 12 years old: spray 1 dose of the drug (3 pressings on the dispenser) along the back wall of the oropharynx every 3-6 hours, no more than 5 doses within 24 hours.

Duration of therapy: no more than 3 days.

Do not inhale when spraying.

Before the first use of the drug, it is necessary to make at least four clicks on the dispenser in the opposite direction until a uniform spray appears.

Before each subsequent use, it is necessary to make at least one press on the dispenser in the opposite direction from you until a uniform spray appears.

Information on technical characteristics, delivery set, country of manufacture

Submit your review to Earn 10 Reward Points click here to login

Write Your Own Review
You're reviewing:Strepsils Intensive spray d / mestn. apply. dosage 8.75mg / dose vial 15ml

 Job in company (10-20 minutes a day | 400 - 1200 USD)! 

We are looking for partners!

 If you have PayPal and you are ready to earn in our team - contact us: [email protected] 

Copyright © 2011-2024 Buy-Pharm, Inc. All rights reserved.